Company: NCEL
Filing Date: 2025-05-16
Form Type: 20-F
Source: 0001213900-25-044868
Chunk: 348

Company: NewcelX Ltd.
Filing Date: 2025-05-16
Form: 20-F
Item: Item 19
Chunk 348
---
  Issuance of common shares upon debt conversion                     -              493,986        434,273        2,354,377       -                 -                 2,788,650  
  Exercise of pre-funded warrants                                    -              191,431        173,123        -               -                 -                   173,123  
  Equity issuance costs                                                                                           ( 386,332                                           ( 386,332  
  Stock based compensation                                           -              -              -              125,644         -                 -                   125,644  
  Defined pension plan adjustments                                   -              -              -              -               -                 266,924             266,924  
  Deemed dividend                                                    -              -              -              2,076,180       ( 2,076,180       -                         -  
  Net loss                                                           -              -              -              -               ( 1,980,810       -               ( 1,980,810  
  BALANCE, DECEMBER 31, 2024                                         206,452        3,159,535      2,740,958      72,820,671      ( 74,430,474      108,853           1,406,361  

Adjusted for the effect of a 1-to-40 reverse share split that was effective
September 27, 2024 (See note 2).

The accompanying notes are an integral part of
these consolidated financial statements.

F-7

NLS PHARMACEUTICS LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                                   For the Years Ended December 31,                                                                           
                                                                                   2024                                                   2023                        2022                    
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Cash Flows From Operating Activities:                                                                                                                                                       
  Net loss                                                                         $                                     ( 1,980,810      $         ( 12,172,029      $         ( 16,495,680  
  Adjustments to reconcile net loss to net cash used in operating activities:                                                                                                                 
  Periodic pension costs                                                                                                 6,239                      59,526                          ( 34,142  
  Depreciation expense                                                                                                   3,321                      11,408                            11,408  
  Stock-based compensation                                                                                               125,644                    164,